Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller at Pfizer, reports the acquisition of 55 phantom stock units through the Pfizer Supplemental Savings Plan.

Summary

• On April 30, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 55 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the derivative security is $25.62.
• Following the transaction, Damico directly owns 27,920 shares.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and there is no indication of positive or negative sentiment. It simply reports a transaction related to executive compensation.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock.

Future Outlook

The phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. Phantom stock units are a common form of deferred compensation used by many large corporations, including Pfizer, to incentivize and retain key employees.

Comparison to Industry Standards

• Pfizer's executive compensation practices, including the use of phantom stock units, are generally in line with those of other large pharmaceutical companies such as Johnson & Johnson (JNJ), Merck (MRK), and AbbVie (ABBV).
• These companies often use a mix of salary, stock options, restricted stock units (RSUs), and performance-based bonuses to compensate their executives.
• The specific mix and terms of these compensation elements can vary depending on the company's performance, industry trends, and individual executive's contributions.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency into executive compensation, which is of interest to shareholders.

Key Dates